Osong Public Health and Research Perspectives

The urgency of improving research infrastructure and institutional frameworks for the next pandemic: Jong-Koo Lee; Osong Public Health Res Perspect. 2024;15(6):477-478. Published online December 30, 2024; DOI: https://doi.org/10.24171/j.phrp.2024.0361

328 View
53 Download

PDF

Comparison and consideration of vaccine injury compensation programs in the Republic of Korea, Japan, and Taiwan: Cho Ryok Kang, Young June Choe, Jihyun Moon, Dooyoung Kim, Taemi Kim, Jong-Koo Lee; Osong Public Health Res Perspect. 2024;15(6):479-488. Published online November 12, 2024; DOI: https://doi.org/10.24171/j.phrp.2024.0129

701 View
34 Download

Graphical Abstract Abstract PDF: This study aimed to establish a foundation for future collaborations aimed at preparing for and responding to infectious diseases by examining the vaccine injury compensation programs (VICPs) of East Asian countries. We reviewed the current status of VICPs in the Republic of Korea, Japan, and Taiwan by searching national government websites and reviewing relevant literature. Additionally, we conducted email inquiries targeting experts from Japan and Taiwan. Through the comprehensive analysis of VICPs in these 3 countries covered various aspects, we identified several similarities and differences in the VICPs across these countries. While the governments of the Republic of Korea, Japan, and Taiwan play a central role in supporting investigations into vaccine injuries and managing compensation procedures based on legal statutes, they differ in terms of financial resources for compensation, the range of vaccines covered, and the criteria for assessing causality. In the Republic of Korea, Japan, and Taiwan, compensation is typically paid in a lump sum, although the specific benefits available vary by country. This study on VICPs in the Republic of Korea, Japan, and Taiwan provides valuable insights for the further development and management of domestic systems.

Which infectious diseases are currently posing problems in the Republic of Korea? One out of every two tuberculosis patients is over 65 years old: Jong-Koo Lee; Osong Public Health Res Perspect. 2024;15(5):383-384. Published online October 31, 2024; DOI: https://doi.org/10.24171/j.phrp.2024.0301

410 View
174 Download

PDF

Preparedness for the recent increase in COVID-19 cases: Jong-Koo Lee; Osong Public Health Res Perspect. 2024;15(4):265-266. Published online August 29, 2024; DOI: https://doi.org/10.24171/j.phrp.2024.0236

768 View
160 Download

PDF

Strengthening the health system, including innovative budget mobilization, is an urgent issue for the Expanded Programme on Immunization: Jong-Koo Lee; Osong Public Health Res Perspect. 2024;15(3):187-188. Published online June 27, 2024; DOI: https://doi.org/10.24171/j.phrp.2024.0181

1,268 View
166 Download

PDF

Peacetime preparedness for the vaccine adverse event: Jong-Koo Lee; Osong Public Health Res Perspect. 2024;15(2):95-96. Published online April 30, 2024; DOI: https://doi.org/10.24171/j.phrp.2024.0113

1,326 View
152 Download

PDF

The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea: Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi; Osong Public Health Res Perspect. 2024;15(2):97-106. Published online April 4, 2024; DOI: https://doi.org/10.24171/j.phrp.2023.0343

2,858 View
106 Download
3 Web of Science
2 Crossref

Graphical Abstract Abstract PDF

The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination. This initiative was requested by the Korea Disease Control and Prevention Agency and led by the National Academy of Medicine of Korea. In September 2022, the COVID-19 Vaccine Safety Research Center was established, strengthening CoVaSC’s initiatives. The center has conducted various studies on the safety of COVID-19 vaccines. During CoVaSC’s second research year, from September 29, 2022 to July 19, 2023, the center was restructured into 4 departments: Epidemiological Research, Clinical Research, Communication & Education, and International Cooperation & Policy Research. Its main activities include (1) managing CoVaSC and the COVID-19 Vaccine Safety Research Center, (2) surveying domestic and international trends in AE causality investigation, (3) assessing AEs following COVID-19 vaccination, (4) fostering international collaboration and policy research, and (5) organizing regular fora and training sessions for the public and clinicians. Causality assessments have been conducted for 27 diseases, and independent research has been conducted after organizing ad hoc committees comprising both epidemiologists and clinical experts on each AE of interest. The research process included protocol development, data analysis, interpretation of results, and causality assessment. These research outcomes have been shared transparently with the public and healthcare experts through various fora. The COVID-19 Vaccine Safety Research Center plans to continue strengthening and expanding its research activities to provide reliable, high-quality safety information to the public.

Citations

Citations to this article as recorded by

SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review
Avraham Ishay, Kira Oleinikov, Elena Chertok Shacham
Vaccines.2024; 12(7): 750. CrossRef
Active Surveillance for Safety Monitoring of XBB.1.5-Containing COVID-19 mRNA Vaccines in Korea
Bomi Park, Hye Ah Lee, Yeonjae Kim, Chung Ho Kim, Hyunjin Park, Seunghee Jun, Hyelim Lee, Seunghyun Lewis Kwon, Yesul Heo, Hyungmin Lee, Hyesook Park
Journal of Korean Medical Science.2024;[Epub] CrossRef

What are the strategies for national health security in preparation for the next pandemic?: Jong-Koo Lee; Osong Public Health Res Perspect. 2024;15(1):1-2. Published online February 28, 2024; DOI: https://doi.org/10.24171/j.phrp.2024.0056

1,322 View
196 Download

PDF

How to transform the medical care system after the COVID-19 pandemic: Jong-Koo Lee; Osong Public Health Res Perspect. 2023;14(6):439-440. Published online December 28, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0382

1,247 View
165 Download

PDF

To combat COVID-19 and prepare for future pandemics, public trust and communication are essential: Jong-Koo Lee; Osong Public Health Res Perspect. 2023;14(5):329-332. Published online October 31, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0317

1,682 View
153 Download
1 Web of Science
1 Crossref

PDF

Citations

Citations to this article as recorded by

Análisis bibliométrico sobre publicación en estudios de comunicación en revistas científicas latinoamericanas durante el período de 2020 a 2023
Felipe Anderson Rios Incio, Ángel Páez Moreno, Luis Ernesto Paz Enrique
Biblios Journal of Librarianship and Information S.2024; (87): e001. CrossRef

How we can prevent a resurgence this year: Jong-Koo Lee; Osong Public Health Res Perspect. 2023;14(4):233-234. Published online August 30, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0235

1,295 View
154 Download

PDF

Neglected issues related to the COVID-19 pandemic: Jong-Koo Lee; Osong Public Health Res Perspect. 2023;14(3):149-150. Published online June 30, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.14.3.01

1,556 View
69 Download

PDF

To become a more stronger and safer country: Jong-Koo Lee; Osong Public Health Res Perspect. 2023;14(2):67-69. Published online April 28, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0105

1,600 View
55 Download

PDF

A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee: Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi; Osong Public Health Res Perspect. 2023;14(1):5-14. Published online February 28, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0026

4,501 View
175 Download
8 Web of Science
7 Crossref

Graphical Abstract Abstract PDF

With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases.

Citations

Citations to this article as recorded by

Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study
Suyeon Kim, Hwa Yeon Ko, Jeongin Oh, Dongwon Yoon, Ju Hwan Kim, Young June Choe, Ju-Young Shin
Journal of Korean Medical Science.2025;[Epub] CrossRef
The association between acute transverse myelitis and COVID‐19 vaccination in Korea: Self‐controlled case series study
Eunsun Lim, Yoo Hwan Kim, Na‐Young Jeong, Su‐Hyun Kim, Heehyun Won, Jong‐Seok Bae, Nam‐Kyong Choi
European Journal of Neurology.2025;[Epub] CrossRef
Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis
Ju Hwan Kim, Dongwon Yoon, Hwa Yeon Ko, Kyungyeon Jung, Jun-Sang Sunwoo, Won Chul Shin, Jung-Ick Byun, Ju-Young Shin
BMC Medicine.2024;[Epub] CrossRef
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi
Osong Public Health and Research Perspectives.2024; 15(2): 97. CrossRef
A Causality Assessment Framework for COVID-19 Vaccines and Adverse Events at the COVID-19 Vaccine Safety Research Center
Seyoung Kim, Jeong Ah Kim, Hyesook Park, Sohee Park, Sanghoon Oh, Seung Eun Jung, Hyoung-Shik Shin, Jong Koo Lee, Hee Chul Han, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi, Dong-Hyun Kim
Journal of Korean Medical Science.2024;[Epub] CrossRef
To become a more stronger and safer country
Jong-Koo Lee
Osong Public Health and Research Perspectives.2023; 14(2): 67. CrossRef
Risk of lymphadenopathy from SARS-CoV-2 vaccination in Korea: a self-controlled case series analysis
Mi-Sook Kim, Bongyoung Kim, Jeong Pil Choi, Nam-Kyong Choi, Jung Yeon Heo, Jun Yong Choi, Joongyub Lee, Sang Il Kim
Epidemiology and Health.2023; 45: e2023090. CrossRef

How we will reach a safer community: Jong-Koo Lee; Osong Public Health Res Perspect. 2023;14(1):1-4. Published online February 27, 2023; DOI: https://doi.org/10.24171/j.phrp.2023.0057

1,529 View
61 Download

PDF

Search